title: Linezolid use in ventilator-associated pneumonia: look at the body weight of your patient!
authors.forename: G
authors.initials: G
authors.lastname: De Pascale
authors.forename: S
authors.initials: S
authors.lastname: Fortuna
authors.forename: P
authors.initials: P
authors.lastname: Navarra
authors.forename: M
authors.initials: M
authors.lastname: Antonelli
mesh_terms: D000081:Acetamides / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D019540:Area Under Curve; D001835:Body Weight / Q000502:physiology*; D006801:Humans; D000069349:Linezolid; D055624:Methicillin-Resistant Staphylococcus aureus; D009765:Obesity / Q000378:metabolism; D023303:Oxazolidinones / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D053717:Pneumonia, Ventilator-Associated / Q000188:drug therapy* / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid